Search

everythinglearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Computer-aided imaging system accurately measures baldness in Chinese women with hair loss.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Trichoscopy is a useful tool for diagnosing different hair and scalp diseases by their unique visual features.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Testosterone's effects on COVID-19 are unclear and need more research.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Vitamin A levels don't significantly affect alopecia areata.

Vitamin A levels don't significantly affect alopecia areata.

Older men's scalp damage increases with age and sun exposure, a baby girl in the Philippines has Schimmelpenning syndrome, and thyroid screening is advised for children with hair loss and certain risk factors.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Higher IL-17A levels indicate more severe alopecia areata.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Hair loss in young men in Central India is linked to severe heart disease.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

Hair thickness differences help diagnose hair loss severity.

Parental socioeconomic status doesn't improve dietary habits or reduce disease severity in children with sickle cell disease.

More severe alopecia areata can lower quality of life.

Severe COVID-19 often leads to hair loss in India.

Tailoring COVID-19 measures to risk levels in the military improves health and readiness.

Collider bias can distort our understanding of COVID-19 risk and severity.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.

Higher apelin-12 levels may indicate more severe acne.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

Higher sebum levels are linked to more severe male baldness.